| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0304-3835(03)00146-0 |
| P698 | PubMed publication ID | 12706860 |
| P2093 | author name string | Rachel Haimovitz | |
| Meir Shinitzky | |||
| Saar Tal | |||
| Keren Mammon | |||
| Tali Eilon | |||
| Anat Tene | |||
| Yael Karmel | |||
| Yechiel Goldman | |||
| Yosef Adan | |||
| P2860 | cites work | Sequence and expression of human estrogen receptor complementary DNA | Q24299678 |
| Cloning of the human estrogen receptor cDNA | Q24610825 | ||
| NF-kappaB regulation in the immune system | Q28205043 | ||
| Peptide antagonists of the human estrogen receptor | Q30633677 | ||
| Differential expression of an estrogen receptor messenger RNA containing exon 1' sequences in MCF-7 breast cancer cell line stocks | Q30840194 | ||
| PMC42, a novel model for the differentiated human breast | Q31848881 | ||
| The role of p53-target genes in human cancer | Q33861549 | ||
| Estrogen receptor variants | Q33923691 | ||
| The loss of estrogen and progesterone receptor gene expression in human breast cancer | Q33923695 | ||
| Approaches targeted to estrogen receptors for treatment of tamoxifen-resistant breast cancer: a brief overview | Q34092529 | ||
| Measurement of steroid hormone receptors in breast cancer patients on tamoxifen | Q34345668 | ||
| A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases. | Q35976663 | ||
| Oestrogen receptor-alpha variant mRNA expression in primary human breast tumours and matched lymph node metastases | Q36618787 | ||
| Differentiation and cancer in the mammary gland: shedding light on an old dichotomy. | Q37401876 | ||
| Second generation hybrid polar compounds are potent inducers of transformed cell differentiation. | Q37550149 | ||
| The control of hematopoiesis and leukemia: from basic biology to the clinic | Q37603531 | ||
| Expression of progesterone receptor in the neonatal rat brain cortex: detection of its mRNA using reverse transcription-polymerase chain reaction | Q38330247 | ||
| Phase I/II trial of tamoxifen with or without fenretinide, an analog of vitamin A, in women with metastatic breast cancer | Q38533095 | ||
| Mechanisms of reversion. | Q40831449 | ||
| The growth and metastasis of human, HER-2/neu-overexpressing tumor cell lines in male SCID mice | Q40857892 | ||
| Estrogen receptor variants and mutations. | Q40884276 | ||
| Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer | Q40991516 | ||
| Retinoids in cancer chemoprevention. | Q41108297 | ||
| Induced differentiation, the cell cycle, and the treatment of cancer | Q41293346 | ||
| Control of mammary tumor cell growth in vitro by novel cell differentiation and apoptosis agents | Q41916902 | ||
| Induction of intracellular signalling by cyclic glycerophosphates and their deoxy analogues | Q42802586 | ||
| Neuronal outgrowth and rescue induced by cyclic phosphates in PC12 cells | Q43806989 | ||
| The pathophysiological role of estrogen receptor variants in human breast cancer. | Q47703304 | ||
| Estrogen receptor mediated inhibition of cancer cell invasion and motility: an overview | Q47703332 | ||
| Sodium butyrate induces differentiation in breast cancer cell lines expressing the estrogen receptor | Q68153690 | ||
| The regulation of estrogen receptor expression and function in human breast cancer | Q74549012 | ||
| Recent advances in breast cancer biology | Q77565928 | ||
| Identification of signal transduction pathways involved in constitutive NF-kappaB activation in breast cancer cells | Q77962336 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | phenotypic differentiation | Q124202013 |
| P304 | page(s) | 67-79 | |
| P577 | publication date | 2003-05-01 | |
| P1433 | published in | Cancer Letters | Q326372 |
| P1476 | title | Phenotypic differentiation of human breast cancer cells by 1,3 cyclic propanediol phosphate | |
| P478 | volume | 194 |
Search more.